Skip to main content
Clinical Trials/NCT06718361
NCT06718361CompletedNot Applicable

Assessing Environmental Oxygen Levels During Artificial Ventilation and Oxygen Therapy: Prospective Observational Study

David Peran, PhD, FERC1 site in 1 country50 target enrollmentStarted: February 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Oxygen levels

Study Overview

Brief Summary

European Resuscitation Council 2021 Guidelines and Advanced Life Support Provider Courses teach that the oxygen supply must be removed from the patient during defibrillation to the distance of minimum of 1 meter. Scientific articles describe few incidents of fire during defibrillation in oxygen - enriched atmospheres.

The study aims to performed a series of measurement of the oxygen concentration in the environment around the patient with different airway management used and ventilation provided.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients at the intensive care unit bed or on the operating theatre with oxygen therapy prescribed/indicated

Exclusion Criteria

  • •no oxygen therapy started
  • •situation not allowing measurement

Outcomes

Primary Outcomes

Oxygen levels

Time Frame: From the initiation of oxygen therapy at the start of anesthesia induction until the completion of oxygen therapy at the end of the procedure (ranging from 30 minutes to 6 hours), oxygen concentration will be assessed continuously.

The oxygen levels in percentage

Secondary Outcomes

  • Normal oxygen levels after the end of oxygen therapy(From the end of oxygen therapy at the completion of procedure until the reappearance of normal oxygen levels (21%), assessed continuously, up to 10 minutes.)

Investigators

Sponsor
David Peran, PhD, FERC
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

David Peran, PhD, FERC

Deputy director

Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O.

Study Sites (1)

Loading locations...

Similar Trials